『#617 The Truth About Cholesterol & Plaque Regression with Dave Feldman』のカバーアート

#617 The Truth About Cholesterol & Plaque Regression with Dave Feldman

#617 The Truth About Cholesterol & Plaque Regression with Dave Feldman

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

The Truth About Cholesterol, LDL, and Plaque Regression with Dave Feldman | Lean Mass Hyper-Responder Research Explained

What if everything you've been told about cholesterol and heart disease is incomplete — or even wrong?

In this eye-opening episode of The Coach Debbie Potts Show, I sit down with Dave Feldman, engineer turned citizen scientist, founder of Own Your Labs and The Citizen Science Foundation, and the mind behind the Lean Mass Hyper-Responder (LMHR) study and the groundbreaking Keto-CTA trial on plaque progression and regression.

We unpack the latest findings from Dave's multi-platform coronary imaging study — comparing HeartFlow, QAngio, Cleerly, and expert readouts — to explore how some individuals with very high LDL cholesterol and low inflammation show no increase in plaque and, in some cases, true regression.

You'll learn:

  • 🧬 What the Lipid Energy Model reveals about metabolism and cholesterol transport

  • 🩸 Why LDL-C and ApoB aren't always the villains — and when they actually matter

  • 🧠 What "soft" vs. "hard" plaque really means for your risk

  • 🩺 The best ways to measure and track plaque (CAC vs. CCTA vs. AI-based imaging)

  • ⚡ How insulin resistance, inflammation, and oxidative stress drive true cardiovascular risk

  • 🥑 Why many keto and low-carb athletes become "Lean Mass Hyper-Responders" — and what to do about it

Whether you're a clinician, health coach, or curious biohacker, this conversation will completely change the way you think about cholesterol, cardiovascular disease, and metabolic health.

🔍 Topics Covered:

00:00 – Intro & Dave Feldman bio
03:00 – The cholesterol paradox in metabolically healthy individuals
08:00 – The Lipid Energy Model explained
12:00 – What is plaque? (Soft vs. hard)
16:00 – How the Keto-CTA study tracked plaque regression
25:00 – The role of LDL, ApoB, and Lp(a) in context
33:00 – Imaging tools: CAC vs. CCTA vs. AI platforms
42:00 – Insulin resistance, inflammation, and endothelial damage
54:00 – Root cause solutions for cardiovascular health

💡 Key Takeaways:
  • Cholesterol is not the enemy — context and inflammation are.

  • The best way to manage heart disease risk is to measure plaque, not just LDL.

  • Metabolic health > cholesterol numbers when it comes to longevity.

  • Functional and nutritional therapy can stabilize or reverse soft plaque.

🔗 Connect & Learn More:

🌐 Website: www.DebbiePotts.net
🎧 Podcast: The Coach Debbie Potts Show
📺 YouTube: @CoachDebbiePotts
🧬 Learn about Root Cause Revolution™: www.rootcausedoc.com
🩺 Explore Own Your Labs: https://ownyourlabs.com
📚 Read more about the Keto-CTA study: https://citizensciencefoundation.org

🧠 Affiliate Links & Partners:

💊 Functional Nutrition Favorites — Fullscript Dispensary
🧬 Seeking Health Supplements — Code COACHDEBBIEPOTTS
🌿 BEAM Minerals — Code COACHDEBBIEPOTTS
💡 Sunlighten Sauna — Mention Coachdebbiepotts for savings

#Cholesterol #DaveFeldman #HeartHealth #ApoB #LDL #PlaqueRegression #KetoDiet #MetabolicHealth #FunctionalMedicine #RootCauseRevolution #CoachDebbiePotts

まだレビューはありません